Drug, herb, and dietary supplement hepatotoxicity

International Journal of Molecular Sciences

Volumn 17, Issue 9, 2016, Pages

  Teschke, Rolf ^a   Andrade, Raúl J ^b,c  

^a GOETHE UNIVERSITY   (Germany)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BILE SALT EXPORT PUMP; BIOLOGICAL MARKER; CARBAMAZEPINE; CYPROTERONE; DICLOFENAC; FENOFIBRATE; FLUCLOXACILLIN; HERBACEOUS AGENT; INFLIXIMAB; ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; LAPATINIB; LEUKOCYTE ANTIGEN; LUMIRACOXIB; METHOTREXATE; NIMESULIDE; NITROFURANTOIN; PARACETAMOL; PHENYTOIN; PYRROLIZIDINE ALKALOID; TERBINAFINE; THIAMAZOLE; TICLOPIDINE; TUBERCULOSTATIC AGENT; XIMELAGATRAN; PLANT EXTRACT;

ALCOHOL LIVER DISEASE; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; DIET SUPPLEMENTATION; EDITORIAL; EQUISETUM; HEPATITIS A; HEPATITIS E; HERB INDUCED LIVER INJURY; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER INJURY; LIVER TOXICITY; MORUS ALBA; NONHUMAN; ROSEMARY; SCOPARIA DULCIS; SOUR ORANGE; TARAXACUM OFFICINALE; TILIA; TOXIC HEPATITIS; ANIMAL; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETARY SUPPLEMENT; PATHOLOGY;

ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETARY SUPPLEMENTS; HUMANS; PLANT EXTRACTS;

EID: 84985898284     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17091488     Document Type: Editorial

References (13)

1. Special Issue “Drug, Herb, and Dietary Supplement Hepatotoxicity”. Int. J. Mol. Sci. Available online: http://www.mdpi.com/journal/ijms/special_issues/Hepatotoxicity (accessed on 15 August 2016).
2. Danan, G.; Teschke, R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int. J. Mol. Sci. 2016, 17
3. Hayashi, P.H. Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. Int. J. Mol. Sci. 2016, 17
4. Björnsson, E.S. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int. J. Mol. Sci. 2016, 17
5. Ortega-Alonso, A.; Stephens, C.; Lucena, M.I.; Andrade, R.J. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int. J. Mol. Sci. 2016, 17
6. Bessone, F.; Hernandez, N.; Lucena, M.I.; Andrade, R.J.; on behalf of the Latin DILI Network (LATINDILIN) and Spanish DILI Registry. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative. Int. J. Mol. Sci. 2016, 17
7. Frenzel, C.; Teschke, R. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int. J. Mol. Sci. 2016, 17
8. Valdivia-Correa, B.; Gómez-Gutiérrez, C.; Uribe, M.; Méndez-Sánchez, N. Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review. Int. J. Mol. Sci. 2016, 17
9. Douros, A.; Bronder, E.; Andersohn, F.; Klimpel, A.; Kreutz, R.; Garbe, E.; Bolbrinker, J. Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study. Int. J. Mol. Sci. 2016, 17
10. Pantano, F.; Tittarelli, R.; Mannocchi, G.; Zaami, S.; Ricci, S.; Giorgetti, R.; Terranova, D.; Busardò, F.P.; Marinelli, E. Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat. Int. J. Mol. Sci. 2016, 17
11. García-Cortés, M.; Robles-Díaz, M.; Ortega-Alonso, A.; Medina-Caliz, I.; Andrade, R.J. Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int. J. Mol. Sci. 2016, 17
12. Teschke, R.; Eickhoff, A. The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges. Int. J. Mol. Sci. 2016, 17
13. Avigan, M.I.; Mozersky, R.P.; Seeff, L.B. Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. Int. J. Mol. Sci. 2016, 17